<DOC>
	<DOCNO>NCT01309334</DOCNO>
	<brief_summary>Multicenter open-label prospective comparative study PET-scan MRI time diagnosis , 3 cycle induction therapy ( RVD ) completion therapy .</brief_summary>
	<brief_title>Imaging Young Myeloma ( IMAgerie JEune My√©lome )</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>symptomatic de novo multiple myeloma le 65 year age enrol IFM/DFCI clinical trial 66 year age eligible highdose therapy Consindications MRI PETScan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>MRI</keyword>
	<keyword>PET-scan</keyword>
	<keyword>multiple myeloma</keyword>
	<keyword>prognosis</keyword>
	<keyword>pharmacoeconomic analysis</keyword>
</DOC>